Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas
1998

Truncated Midkine as a Marker for Gastrointestinal Cancer

Sample size: 47 publication Evidence: moderate

Author Information

Author(s): K Aridome, S Takao, T Kaname, K Kadomatsu, S Natsugoe, F Kijima, T Aikou, T Muramatsu

Primary Institution: Kagoshima University Faculty of Medicine

Hypothesis

Can truncated midkine mRNA serve as a marker for nodal metastases in gastrointestinal carcinomas?

Conclusion

Truncated midkine mRNA is expressed in various gastrointestinal cancers and could be a useful marker for detecting nodal metastases.

Supporting Evidence

  • Truncated midkine mRNA was expressed in 30 of 46 primary gastrointestinal cancers examined.
  • Truncated midkine was not detected in adjacent non-cancerous tissues.
  • All 14 lymph node metastases from ten cancer patients expressed truncated midkine mRNA.

Takeaway

This study looked at cancer samples to see if a specific marker, called truncated midkine, could help find cancer spread in lymph nodes.

Methodology

The study used polymerase chain reaction (PCR) to analyze the expression of truncated midkine mRNA in 47 surgically removed gastrointestinal cancer specimens.

Limitations

The study had a small sample size and focused only on gastrointestinal cancers.

Participant Demographics

The mean age of participants was 61.5 years, with a male/female ratio of 1.9.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication